Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-11-15
2011-10-11
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S143000
Reexamination Certificate
active
08034829
ABSTRACT:
The present invention relates to 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives represented by general formula D, their pharmacologically acceptable salts thereof, and compositions containing such compounds. Methods for treating hyperproliferative disorders by administering the compounds are also included.
REFERENCES:
patent: 4942163 (1990-07-01), Behrens
patent: 2007/0185160 (2007-08-01), Hattori et al.
patent: 22 43 789 (1973-03-01), None
patent: 2002 0074568 (2002-10-01), None
patent: 0412319 (2003-12-01), None
patent: WO 2005/075431 (2005-08-01), None
patent: WO 2005/075432 (2005-08-01), None
E. M. Kaiser et al., “Facile Synthesis of 1-Amino-3-arylisoquinolines”, Synthesis, No. 11, 1974, pp. 805-806.
P. J. Pijper et al., “Synthesis and antimycoplasmal activity of 2, 2′-bipyridyl analogs,, Part I. 1-Amino-3-(2-pyridyl) isoquinolines”, European Journal of Medicinal Chemistry, vol. 19, No. 5, 1984, pp. 389-392.
H. Van Der Goot et al., “The growth-inhibitory action of some 1-aminoisoquinolines and related compounds on mycoplasma gallisepticum”, European Journal of Medicinal Chemistry, vol. 10, No. 6, 1975, pp. 603-606.
H. Van Der Goot et al., “A new synthesis of 1 aminoisoquinolines” Chimica Therapeutica, vol. 7, No. 3, 1972, pp. 185-188.
W.-J. Cho et al., “Synthesis of New 3-Arylisoquinolinamines: Effect on Topoisomerase I Inhibition and Cytotoxicity”, Bioorganic & Medicinal Chemistry Letters, vol. 13, No. 24, 2003, pp. 4451-4454.
Molecular Modeling of 3-Arylisoquinoline Antitumor Agents Active Against A-549. A Comparative Molecular Field Analysis Study, Bioorganic & Medicinal Chemistry 10, (2002), pp. 2953-2961.
Ahn Chang H.
Cho Won-Jea
Lee Young B.
Davis Zinna Northington
Haddaway Keith G.
Nelson Michael E.
Rexahn Pharmaceuticals, Inc.
Venable LLP
LandOfFree
5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4287306